Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...

Kyverna Therapeutics, Inc. ( ($KYTX) ) has released its Q4 earnings. Here is a breakdown of the information Kyverna Therapeutics, Inc. presented ...

Dimov believes the late-stage trial demonstrates for the first time that people don’t have to “play that trade-off game.” Orca's cell therapy ... are also a “strong confirmation” of ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced non-small cell lung cancer.